Technology News and Research

RSS

Study uncovers a biological role of transmembrane protein TMEM208

A recent study conducted in the lab of Dr. Hugo J. Bellen, distinguished service professor at Baylor College of Medicine and principal investigator at the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital, has discovered a biological role of a specific transmembrane protein called TMEM208.

23 Feb 2024

Research reveals bacteria's dynamic defense duo against phage viruses

Scientists at the University of Southampton have discovered that bacteria can pair up their defense systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.

23 Feb 2024

Key link discovered between spread of antibiotic resistance genes and drug resistance evolution

Biomedical engineers at Duke University have uncovered a key link between the spread of antibiotic resistance genes and the evolution of resistance to new drugs in certain pathogens.

23 Feb 2024

Automated insulin delivery systems: Advancements and future prospects

A special 13-article supplement to the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) examines the "Development and Future of Automated Insulin Delivery (AID) Systems.

23 Feb 2024

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Increased use of Paxlovid, the antiviral drug used to treat COVID-19, could prevent hundreds of thousands of hospitalizations and save tens of billions of dollars a year, according to a new epidemiological model published by researchers at The University of Texas at Austin.

23 Feb 2024

Researchers develop bilayer adhesive hemostat using proteins derived from mussels and silkworms

In recent news, there has been a case where a patient experienced pain due to a surgical procedure involving sutures, resulting in the unintended presence of gauze within the patient's body.

23 Feb 2024

Ketamine variant shows promise in treating social impairments

Well-being is important for everyone, especially when we feel lonely or isolated. Depression is a serious challenge for many people and finding an effective solution is key.

22 Feb 2024

Yale chemists synthesize complex anticancer molecules from marine invertebrates

Nearly 30 years ago, scientists discovered a unique class of anticancer molecules in a family of bryozoans, a phylum of marine invertebrates found in tropical waters.

22 Feb 2024

Innovative MicroGlucagon solution aims to transform insulin therapy for type 1 diabetics

Researchers in Trondheim are developing a new medicine for diabetics who have to have daily injections of insulin. The key is a hormone that causes the smallest blood vessels to relax on the inside.

22 Feb 2024

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

22 Feb 2024

Ginseng enhances muscle recovery and reduces fatigue in athletes

Ginseng is one of the most popular food supplements in the world. It is made out of various plants and herbs and is thought to provide many benefits, with numerous studies pointing at possible anti-inflammatory and antioxidant benefits as well as anti-cancer effects.

22 Feb 2024

Delta opioid receptor agonist reduces anxiety-like behavior in mice

Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals.

22 Feb 2024

LabVantage Solutions Introduces Digital Native Ecosystem for R&D Success

With solutions to decrease redundant experiments, improve design of experiments, derive greater insights from data, and automate laboratory workflows, LabVantage Solutions equips R&D labs for success in innovation. Introducing a digital native ecosystem for R&D, LabVantage addresses researchers’ needs in three broad categories of semantic search, analytics, and automation.

From LabVantage Solutions 22 Feb 2024

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology company with a therapeutic focus on neurodegenerative disease, to develop Optimer binders for a lateral flow test for the early diagnosis of Alzheimer’s disease

From Aptamer Group 22 Feb 2024

Youth fitness linked to lower atherosclerosis risk in middle-aged men

Men who were physically fit when they were young had a lower risk of atherosclerosis almost 40 years later, according to a study led by researchers at Linköping University, Sweden.

22 Feb 2024

SCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometry

SCIEX’s Reveals How They're Setting New Standards in Mass Spectrometry at SLAS 2024.

From Society for Laboratory Automation and Screening (SLAS) 22 Feb 2024

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

A simple blood test to diagnose Alzheimer's disease soon may replace more invasive and expensive screening methods such as spinal taps and brain scans.

22 Feb 2024

Red light exposure mitigates blood glucose spikes after meals

Shining a specific frequency of red light on a person's back for 15 minutes can reduce blood sugar levels, according to a new study from City, University of London and UCL.

22 Feb 2024

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.

From Selkirk Pharma 22 Feb 2024

Novel treatment for polycythemia vera shows promise in clinical trial

A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount Sinai.

21 Feb 2024

Technology News and Research

Study uncovers a biological role of transmembrane protein TMEM208

Research reveals bacteria's dynamic defense duo against phage viruses

Key link discovered between spread of antibiotic resistance genes and drug resistance evolution

Automated insulin delivery systems: Advancements and future prospects

Increased paxlovid use could lead to significant hospitalization reductions and cost savings

Researchers develop bilayer adhesive hemostat using proteins derived from mussels and silkworms

Ketamine variant shows promise in treating social impairments

Yale chemists synthesize complex anticancer molecules from marine invertebrates

Innovative MicroGlucagon solution aims to transform insulin therapy for type 1 diabetics

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

Ginseng enhances muscle recovery and reduces fatigue in athletes

Delta opioid receptor agonist reduces anxiety-like behavior in mice

LabVantage Solutions Introduces Digital Native Ecosystem for R&D Success

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

Youth fitness linked to lower atherosclerosis risk in middle-aged men

SCIEX’s Jose Castro-Perez Reveals How They're Setting New Standards in Mass Spectrometry

Simple blood test to detect Alzheimer's disease may replace more invasive diagnostic methods

Red light exposure mitigates blood glucose spikes after meals

Selkirk Pharma announces new APS qualified facility with advanced fill/finish capacity in Spokane, WA

Novel treatment for polycythemia vera shows promise in clinical trial

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News